PhRMA urges USTR to protect US innovation abroad

13-02-2017

PhRMA urges USTR to protect US innovation abroad

Bet_Noire / iStockphoto.com

The Pharmaceutical Research and Manufacturers of America (PhRMA) has urged the US Trade Representative (USTR) to protect US innovators abroad.


PhRMA, USTR, innovation, patent, Special 301 Report, medicines, IP protection, market access, barriers, biopharmaceutical

LSIPR